2. Participants' disposition of included studies.
| Study name | Intervention(s) and comparator(s) | Screened/eligible (n) | Randomised (n) | Treatment completion (n (%)) | Analysed (n (%)) |
| Di Stasi 2003 | MMC‐EMDA induction after TURBT | Not reported/117 | 36 | 36 (100) | 36 (100) |
| MMC‐PD induction after TURBT | 36 | 36 (100) | 36 (100) | ||
| BCG induction after TURBT | 36 | 36 (100) | 36 (100) | ||
| Total | 108 | 108 (100) | 108 (100) | ||
| Di Stasi 2006 | MMC‐EMDA with sequential BCG induction and maintenance after TURBT | 241/212 | 107 | 96 (89) | 107 (100) |
| BCG induction and maintenance after TURBT | 105 | 94 (89) | 105 (100) | ||
| Total | 212 | 190 (89) | 212 (100) | ||
| Di Stasi 2011 | Single‐dose, MMC‐EMDA before TURBT | 398/374 | 124 | 117 (94) | 117 (94) |
| Single‐dose, MMC‐PD immediately after TURBT | 126 | 119 (94) | 119 (94) | ||
| TURBT alone | 124 | 116 (93) | 116 (93) | ||
| Total | 374 | 352 (94) | 352 (94) | ||
| Grand total | 694 | 650 (93) | 672 (96) | ||
BCG: Bacillus Calmette‐Guérin; MMC‐EMDA: electromotive drug administration of mitomycin C; MMC‐PD: passive diffusion of mitomycin C; n: number of participants; TURBT: transurethral resection of bladder tumour.